GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » Altman Z-Score

Synthetic MR AB (XSAT:SYNT) Altman Z-Score : 29.70 (As of May. 11, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 28.66 is strong.

Synthetic MR AB has a Altman Z-Score of 29.70, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Synthetic MR AB's Altman Z-Score or its related term are showing as below:

XSAT:SYNT' s Altman Z-Score Range Over the Past 10 Years
Min: 27.34   Med: 68.82   Max: 104.99
Current: 28.66

During the past 12 years, Synthetic MR AB's highest Altman Z-Score was 104.99. The lowest was 27.34. And the median was 68.82.


Synthetic MR AB Altman Z-Score Historical Data

The historical data trend for Synthetic MR AB's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB Altman Z-Score Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.19 88.31 104.99 43.83 27.34

Synthetic MR AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.83 44.59 32.26 29.84 27.34

Competitive Comparison of Synthetic MR AB's Altman Z-Score

For the Health Information Services subindustry, Synthetic MR AB's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB's Altman Z-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's Altman Z-Score falls into.



Synthetic MR AB Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Synthetic MR AB's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.6449+1.4*0.304+3.3*0.0993+0.6*45.9227+1.0*0.624
=29.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was kr142.97 Mil.
Total Current Assets was kr118.36 Mil.
Total Current Liabilities was kr26.16 Mil.
Retained Earnings was kr43.47 Mil.
Pre-Tax Income was 6.744 + 4.536 + 4.03 + -2.229 = kr13.08 Mil.
Interest Expense was -0.914 + 0 + 0 + -0.207 = kr-1.12 Mil.
Revenue was 30.119 + 21.708 + 21.244 + 16.142 = kr89.21 Mil.
Market Cap (Today) was kr1,212.04 Mil.
Total Liabilities was kr26.39 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(118.362 - 26.158)/142.965
=0.6449

X2=Retained Earnings/Total Assets
=43.466/142.965
=0.304

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(13.081 - -1.121)/142.965
=0.0993

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=1212.038/26.393
=45.9227

X5=Revenue/Total Assets
=89.213/142.965
=0.624

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Synthetic MR AB has a Altman Z-Score of 29.70 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Synthetic MR AB  (XSAT:SYNT) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Synthetic MR AB Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Syntel Joins Google Cloud Partner Program

By Marketwired Marketwired 03-26-2018

Syntel to Present at Investor Conference

By Marketwired Marketwired 05-10-2018

Syntel Inc. (SYNT) Chairman, 10% Owner Bharat Desai sells 105,384 Shares

By GuruFocus Research GuruFocus Editor 12-16-2010

Syntel Inc. (SYNT) CEO and President Prashant Ranade sells 3,000 Shares

By GuruFocus Research GuruFocus Editor 12-21-2010

Syntel enters definitive agreement to be acquired by Atos S.E.

By GlobeNewswire GlobeNewswire 07-22-2018

Syntel Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-08-2010

Syntel: A contrarian's delight

By nicklaskastrup Dhandoisms 05-15-2015